Factor VIII (HemoRel)

✓ Approved

Reliance Life Sciences Private Limited · F8 · Cell-based Therapies

What is Factor VIII?

Factor VIII is a cell-based therapies developed by Reliance Life Sciences Private Limited. It is approved for therapeutic indications via injectable (others) or intravenous (iv).

Drug Profile

Brand Names	HemoRel
Company	Reliance Life Sciences Private Limited
Drug Class	Cell-based Therapies
Molecular Target	F8
Route	Injectable (Others), Intravenous (IV)
Status	Approved

Sources: ClinicalTrials.gov, Reliance Life Sciences Private Limited

Mechanism of Action

Molecular Targets

Factor VIII acts on 1 molecular target:

F8	coagulation factor VIII (AHF, FVIII)

Want deeper analysis?Noah AI can explain complex mechanisms and compare to similar drugs.

Therapeutic Indications

Factor VIII is developed for 1 unique indication across 1 therapeutic area.

Therapeutic Area	Condition	Phase
Congenital, familial and genetic disorders	Factor VIII deficiency	✓ Approved